Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer

British Journal of Cancer

Volumn 76, Issue 5, 1997, Pages 639-642

  Gogas, H ^a   Lofts, F J ^a   Evans, T R J ^a   Millard, F J C ^a   Wilson, R ^b   Mansi, J L ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Epirubicin; Etoposide; SCLC

Indexed keywords

EPIRUBICIN; ETOPOSIDE;

ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; COUGHING; DIARRHEA; DRUG EFFICACY; DYSPNEA; FEMALE; HEMOPTYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OUTPATIENT; PAIN; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING; WEIGHT GAIN;

EID: 0030758209     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.438     Document Type: Article

References (23)

1. Ahrall RP, Willcox PA and Hewitson RH (1987) Etoposide combination therapy for small cell carcinoma of the lung. Cancer Chemother Pharmacol 20: 83-84
2. Albain KS. Crowley JJ, Le Blanc M and Livingston RB (1990) Determinants of improved outcome in small cell lung cancer: An analysis of the 2,580 patient Southwest Oncology Group database. J Clin Oncal 8: 1563-1574
3. Bamberga M, Michetti G. Bamberga P, Ori-Belometti M, Gritti G, Sarti E and Villa R (1992) Cyclophosphamide, epirubicin, etoposide, cisplatinum (CEVP) in combination with radiotherapy: evaluation of a protocol adopted for 6 years in 148 cases of small cell lung cancer. Tumori 78(5): 333-337
4. Blackstein M. Eisenhauer EA, Wierabicki R and Yoshida S (1990) Epirubicin in extensive small cell lung cancer: A phase II study in previously untreated patients. A National Cancer Institute of Canada Clinical Trials Group study. J Clin Oncol 8: 385-389
5. Bleehen NM, Girling DJ, Hopwood P, Lallemand G, Machin D, Stephens RJ and Bailey AJ. MRC Lung Cancer Working Party. (1996) Randomised trial of fourdrug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Br J Cancer 73:406-413
6. Eckhardt S, Kolaric K, Vukas D, Kanitz E, Schoket Z, Jassem J, Vuletic L, Jelic S, Mechl Z, Koza I et al (1990) Phase II study of 4-epi-doxorubicin in patients with untreated extensive small cell lung cancer. Med Oncol Tumor Pharmacother7(1): 19-23
7. Evans WK, Radwi A, Tomiak E, Logan DM, Martins H, Stewart DJ, Goss G, Maroun JA and Dahrouge S (1995) Oral etoposide and carhoplatin: effective therapy for elderly patients with small cell lung cancer. Am J Clin Oncol 18(2): 149-155
8. Hansen HH (1992) Management of small cell cancer of the lung. Lancet 339: 846-849
9. Johnson DH, Kim K, Turnst AT, Sause W, Komaki R, Wagner H and Blum R (1994) Cisplatin and etoposide plus concurrent thoracic radiotherapy administered once versus twice daily for limited-stage small cell lung cancer (abstract). Proc Am Soc Clin Oncol 13: 333
10. Kaplan EL and Meier P (1958) Nonparometric estimation from incomplete observations. J Am Stat Assoc 53: 457-181
11. Klastersky J (1995) Small cell lung cancer: Can treatment results be improved further? Semin Oncol 22 (suppl. 2): 1-2
12. Loehrcr PJ Sr (1995) Palliative therapy: Extensive small cell lung cancer. Semin Oncol 22 (2 suppl. 3): 40-44
13. Loehrer PJ SR, Ansari R, Gonin R, Monaco F, Fisher W, Sandler A and Einhorn LH (1995) Cisplatin plus etoposide with and without ifosfamide in extensive smallcell lung cancer: A Hoosier Oncology Group Study. J Clin Oncol 13: 2594-2599
14. Macchiarini P, Danesi R, Mariotti R, Marchetti A. Fazzi P, Bevilacqua G, Manani M, Giuntini C, Del Tacca M and Angeletti CA (1990a) Phase II study of highdose epirubicin in untreated patients with small cell lung cancer. Am J Clin Oncol 13(4): 302-307
15. Macchiarini P, Chella A, Riva A, Mengozzi G, Silvano G, Solfanelli S and Angelleti CA (1990b) Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small cell lung cancer. Am J Clin Oncol 13: 495-500
16. Pedersen AG and Hansen HH (1983) Etoposide (VP-16) in the treatment of lung cancer. Cancer Treat Rev 10: 245-264
17. Pfeiffer P, Sorensen P and Rose C (1995) Is carboplatin and oral etoposide an effective and feasible regime in patients with small cell lung cancer? Eur J Cancer 31A; 64-69
18. Plosker GL and Faulds D (1993) Epirubicin: A review of its pharmacodynamic and phamacokinetic properties, and therapeutic use in cancer chemotherapy. Drugs 45:788-856
19. Rosell R, Carles J, Abad A, Jimeno JM, Moreno I, Barnada A, Ribelles N and Haboubi N (1992) Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer. Investigational New Drugs 10(2): 123-128
20. Sculier JP, Bureau G, Giner V, Thiriaux J, Michel J, Berchier MC, Van Cutsem O, Kustner U, Kroll F, Mommen P, Paesmans M and Klastersky J (1995) Induction chemotherapy with ifosfamide, etoposide and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party. Semin Oncol 22 (1 suppl. 2): 18-22
21. Slevin ML, Clark PI, Joel SP, Malik S, Osbome RJ, Gregory WM, Lowe DG, Reznek RH and Wrigley PF (1989) A randomised trial to evaluate the effect of schedule on the activity of etoposide in small cell lung cancer. J Clin Oncol 7: 1333-1340
22. Thatcher N, Clark PI, Girling DJ, Hopwood P, Twiddy S, Stephens RJ, Baily AJ and Machin D, MRC Lung Cancer Working Party (1996) Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Lancel 348: 563-566
23. Wolff AC, Ettinger DS, Neuberg D, Comis RL, Ruchdeschel JC, Bonomi PD and Johnson DH (1995) A phase II study of Ifosfamide, carboplatin and oral etoposide chemotherapy for extensive disease small cell lung cancer: An Eastern Cooperative Oncology Group pilot study. J Clin Oncol 13: 1615-1622